KR960000224A - 3, 7-디아자바이사이클로［3, 3, 1］노난- 화합물을 함유한 신규한 약제 - Google Patents

3, 7-디아자바이사이클로［3, 3, 1］노난- 화합물을 함유한 신규한 약제 Download PDF

Info

Publication number
KR960000224A
KR960000224A KR1019950012696A KR19950012696A KR960000224A KR 960000224 A KR960000224 A KR 960000224A KR 1019950012696 A KR1019950012696 A KR 1019950012696A KR 19950012696 A KR19950012696 A KR 19950012696A KR 960000224 A KR960000224 A KR 960000224A
Authority
KR
South Korea
Prior art keywords
diazabicyclo
nonan
compounds
drugs containing
acid addition
Prior art date
Application number
KR1019950012696A
Other languages
English (en)
Inventor
지글러 디이터
브뢰크너 라인하르트
쉔 우웨
Original Assignee
닥터 디이터 라우어
칼리-케미 파마 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 닥터 디이터 라우어, 칼리-케미 파마 게엠베하 filed Critical 닥터 디이터 라우어
Publication of KR960000224A publication Critical patent/KR960000224A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

본 발명은 상부심실성 부정맥증 치료에 쓰이는 약제학적 제제의 제조를 위한 N-이소부틸-N′-이소프로필-9,9-펜타메틸렌-3,70디아자바이사이클로[3,3,1]노난-화합물 및 이의 생리학적으로 허용가능한 산부가 염들에 관한 것이다.

Description

3,7-디아자바이사이클로[3,3,1]노난-화합물을 함유한 신규한 약제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 일반구조식 Ⅰ의 N-이소부틸-N′-이소프로필-9,9-펜타메틸렌-3,70디아자바이사이클로[3,3,1]노난-화합물 및 이의 생리학적으로 허용가능한 산부가염을 함유하는 상부심실성 부정맥증 치료용 약제학적 제제;
  2. 제2항에 따른 일반 구조식 Ⅰ화합물 혹은 이의 생리학적으로 허용가능한 산부가염들을 일반적으로 약제학적 보조제와 함께 적절한 약제 형태로 제조하는 것을 특징으로 하는 상부심실성 부정맥증 치료용 약제학적 제제의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950012696A 1994-06-17 1995-05-20 3, 7-디아자바이사이클로［3, 3, 1］노난- 화합물을 함유한 신규한 약제 KR960000224A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4421324.7 1994-06-17
DE4421324A DE4421324A1 (de) 1994-06-17 1994-06-17 Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
KR960000224A true KR960000224A (ko) 1996-01-25

Family

ID=6520896

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950012696A KR960000224A (ko) 1994-06-17 1995-05-20 3, 7-디아자바이사이클로［3, 3, 1］노난- 화합물을 함유한 신규한 약제

Country Status (17)

Country Link
EP (1) EP0687469A3 (ko)
JP (1) JPH0840900A (ko)
KR (1) KR960000224A (ko)
CN (1) CN1121414A (ko)
AU (1) AU1775695A (ko)
CA (1) CA2152118A1 (ko)
CZ (1) CZ157195A3 (ko)
DE (1) DE4421324A1 (ko)
DZ (1) DZ1893A1 (ko)
FI (1) FI952973A (ko)
HU (1) HUT71815A (ko)
IL (1) IL113398A0 (ko)
NO (1) NO952426L (ko)
NZ (1) NZ270992A (ko)
RU (1) RU95108884A (ko)
SK (1) SK77695A3 (ko)
ZA (1) ZA954690B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2333211C1 (ru) * 2006-11-01 2008-09-10 Институт физиологически активных веществ Российской Академии наук N,n`-замещенные 3, 7-диазабицикло[3.3.1]нонаны, обладающие фармакологической активностью, фармацевтические композиции на их основе и способ их применения
RU2472793C1 (ru) * 2011-07-20 2013-01-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет тонких химических технологий имени М.В. Ломоносова" (МИТХТ им.М.В.Ломоносова) 1,5-бис[(трет-бутиламино)метил]-n,n'-ди-трет-бутилбиспидин-9-она и способ его получения

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NO952426D0 (no) 1995-06-16
JPH0840900A (ja) 1996-02-13
CZ157195A3 (en) 1996-01-17
HU9501728D0 (en) 1995-08-28
FI952973A0 (fi) 1995-06-16
NZ270992A (en) 1997-06-24
DZ1893A1 (fr) 2002-02-17
AU1775695A (en) 1996-01-04
HUT71815A (en) 1996-02-28
EP0687469A2 (de) 1995-12-20
RU95108884A (ru) 1997-05-10
DE4421324A1 (de) 1995-12-21
IL113398A0 (en) 1995-07-31
CN1121414A (zh) 1996-05-01
ZA954690B (en) 1996-01-29
NO952426L (no) 1995-12-18
SK77695A3 (en) 1996-05-08
FI952973A (fi) 1995-12-18
CA2152118A1 (en) 1995-12-18
EP0687469A3 (de) 1996-05-22

Similar Documents

Publication Publication Date Title
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
EP0079556A3 (de) Morphinanderivate, ihre Herstellung, sowie diese enthaltende Arzeimittel
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
KR900014406A (ko) 세펨 화합물 및 이의 제조방법
EP0342587A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
ATE55248T1 (de) Arzneimittelkombination.
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
KR960000224A (ko) 3, 7-디아자바이사이클로［3, 3, 1］노난- 화합물을 함유한 신규한 약제
KR910002442A (ko) 안구질환을 치료하는 방법 및 제약학적 조성물
KR890012942A (ko) 5-치환된 오르니틴 유도체
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
KR900017599A (ko) 종양 치료용 약학 조성물
KR880002521A (ko) 약제 제형
NZ220539A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
RU2032404C1 (ru) Средство для лечения гиповитаминоза b1
DE59002790D1 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO).

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid